Hao Guo
- Oncology top 5%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Molecular Biology
- Co-authors
- Eric P. WinerZhan XuSara M. TolaneyBeth OvermoyerWilliam T. BarryIan E. KropAntonio C. WolffBeverly Moy
- Topics
- HER2/EGFR in Cancer Research (17 papers)Cancer Treatment and Pharmacology (16 papers)Advanced Breast Cancer Therapies (14 papers)
- Partner nations
- United StatesChinaIndia
In The Last Decade
Hao Guo
59 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 898
- Cancer Research 503
- Pulmonary and Respiratory Medicine 303
- Radiology, Nuclear Medicine and Imaging 227
- Molecular Biology 211
Countries citing papers authored by Hao Guo
This map shows the geographic impact of Hao Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Guo more than expected).
Fields of papers citing papers by Hao Guo
This network shows the impact of papers produced by Hao Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Guo. The network helps show where Hao Guo may publish in the future.
Co-authorship network of co-authors of Hao Guo
This figure shows the co-authorship network connecting the top 25 collaborators of Hao Guo. A scholar is included among the top collaborators of Hao Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Guo. Hao Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 13 | |
| 6 | 30 | |
| 7 | 21 | |
| 8 | 6 | |
| 9 | 2 | |
| 10 | 2 | |
| 11 | 26 | |
| 12 | 47 | |
| 13 | 49 | |
| 14 | Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancerbreakdown → | 458 |
| 15 | 42 | |
| 16 | 21 | |
| 17 | 12 | |
| 18 | 11 | |
| 19 | 35 | |
| 20 | 96 |
About Hao Guo
Hao Guo is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 62 papers that have together received 1.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (17 papers), Cancer Treatment and Pharmacology (16 papers) and Advanced Breast Cancer Therapies (14 papers). The work is most often cited by research in Cancer Research (503 citations), Oncology (898 citations) and Radiology, Nuclear Medicine and Imaging (227 citations). Hao Guo has collaborated with scholars based in United States, China and India. Frequent co-authors include Eric P. Winer, Zhan Xu, Sara M. Tolaney, Beth Overmoyer, William T. Barry, Ian E. Krop, Antonio C. Wolff, Beverly Moy, Harold J. Burstein and Matthew J. Ellis. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.